Mannose-Binding Lectin: Clinical Trials

2 trials of Mannose-Binding Lectin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Completed 1

Follow Mannose-Binding Lectin: new trials by email Literature Review of Mannose-Binding Lectin trials Research Report on Mannose-Binding Lectin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
recombinant human mannose-binding lectin - Fever, Sweats, and Hot Flashes, Infection
Phase 1WithdrawnEnzon Pharmaceuticals, Inc.2006-11-012012-06-20
Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Mannan Binding Lectin (MBL), Mannan Binding Lectin - MBL-Deficient, Neutropenia
Phase 2CompletedProthya Biosolutions122004-04-012007-08-30

Conditions studied

Neutropenia (2)  ·  Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Fever (1)  ·  Hot Flashes (1)  ·  Infections (1)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Sponsors

Enzon Pharmaceuticals, Inc. (1)  ·  Prothya Biosolutions (1)

Countries

Netherlands (1)  ·  United States (1)

Top investigators

H N Caron (1)  ·  T W Kuijpers, MD, PdD (1)  ·  Thomas J. Walsh, MD (1)